胰腺腺癌辅助放疗模拟CT图像的诊断价值评估
回顾73例胰腺腺癌辅助放疗患者的模拟CT,由腹部放射科医师与既往CT对比识别新发病灶。检出远处转移4例(5.5%)、局部区域复发5例(6.8%)、不确定病灶32例(43.8%),其中43.7%的不确定病灶经随访证实为恶性。无癌症相关病灶者3年总生存率显著高于有病灶者(44.8% vs 10.8%,p=0.002)。
要点
- 模拟CT上不确定病灶常见于肠系膜上血管旁软组织,占75.0%(24/32)。
- 43.7%的不确定病灶经随访PET-CT和诊断CT证实为恶性局部失败。
- 无癌症相关病灶者的3年总生存率显著高于有病灶者(44.8% vs 10.8%,p=0.002)。
核心结论
- 专业医师审阅模拟CT可检出早期进展或潜在治疗失败,在辅助放疗前应仔细审阅模拟CT。
研究设计与样本
- 回顾性研究,纳入73例接受胰腺腺癌辅助放疗模拟CT扫描的患者,由专业腹部放射科医师将模拟CT与既往CT对比识别新病灶。
关键影像表现/征象
- 新检出癌症相关病灶分为远处转移、局部区域复发和不确定病灶三类。
- 32例不确定病灶中24例(75.0%)为邻近肠系膜上血管的软组织病灶。
诊断标准与关键数值
- 远处转移检出4例(5.5%),局部区域复发检出5例(6.8%),不确定病灶检出32例(43.8%)。
- 不确定病灶中43.7%经随访PET-CT和诊断CT证实为恶性,表现为局部失败。
- 无癌症相关病灶者3年总生存率44.8% vs 有病灶者10.8%,p=0.002。
临床应用与阅片要点
- 模拟CT在辅助放疗前应由专业腹部放射科医师与既往CT对比仔细审阅以识别新发病灶。
- 邻近肠系膜上血管的软组织病灶应视为不确定病灶并在随访影像中评估恶性可能。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The purpose of this study is to review simulation CT scans and evaluate their diagnostic value in patients treated with adjuvant radiotherapy for pancreatic adenocarcinoma.
METHODS: 73 patients who had undergone simulation CT scans for adjuvant radiotherapy in pancreatic adenocarcinoma were reviewed. All simulation CT scans were reviewed by professional abdominal radiologists, who compared the images with corresponding prior CT scans to identify new lesions. Newly detected cancer-related lesions were classified into one of three categories: distant metastasis, locoregional recurrence and indeterminate lesions. Indeterminate lesions were reviewed for malignancy during follow-up imaging work-ups.
RESULTS: Of 73 patients, distant metastasis, locoregional recurrence and indeterminate lesions were found in 4 (5.5%), 5 (6.8%) and 32 patients (43.8%), respectively. Among 32 indeterminate lesions, 24 (75.0%) were soft tissue lesions neighbouring the superior mesenteric vessels. Follow-up PET-CT and diagnostic CT scans revealed that 43.7% of indeterminate lesions were malignant presenting local failures. The 3-year overall survival was significantly higher among patients who had no cancer-related lesions than among who did have such findings (44.8% vs 10.8%, p = 0.002).
CONCLUSION: Professional review of simulation CT scans have ample diagnostic value as they help detect early progressions or potential failures in patients treated with adjuvant radiotherapy for pancreatic adenocarcinoma. Simulation CT scans should be carefully reviewed before the delivery of adjuvant radiotherapy. Advances in knowledge: Generally, simulation CT scan has been known to provide limited diagnostic values and clinical impact. However, the results of this study showed a high detection rate of cancer-related lesions, which could potentially affect subsequent treatment strategies in patients with pancreatic adenocarcinoma.
引用
- Kim B, Kim YC, Noh OK, et al. Diagnostic evaluation of simulation CT images for adjuvant radiotherapy in pancreatic adenocarcinoma. Br J Radiol. 2017. PMID: 28707545. doi:10.1259/bjr.20170225
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。